[Intestinal atresia: what is changed in the last 30 years]
Related Experiment Video
Updated: Nov 8, 2026

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
G B Parigi1, S Minniti, R Bragheri
1IRCCS Policlinico S. Matteo, Università degli Studi di Pavia.
Insights
Management of intestinal atresia has significantly improved over 30 years, with better diagnostics and artificial nutrition enhancing survival rates for neonates. This review details advancements in treating this congenital condition.
Area of Science:
- Pediatric Surgery
- Neonatal Care
- Congenital Malformations
Abstract:
The changes occurred in the management of intestinal atresia in the last 30 years are presented. On the basis of a series of 55 neonates (29 M/26 F; 14 premature; mean body weight 2640 g, range 1340-4100 g; 23 duodenal, 30 small bowel, 2 colon) four aspects of this malformation are discussed; epidemiology, diagnostics, therapy and prognosis. Epidemiology. 40% incidence reduction is detected; unchanged the relative incidence of Down neonates with duodenal atresia. Diagnostics. Prenatal US scan useful in 4 of 8 cases only; emphasized the usefulness of plain X-ray abdomen. Perioperative treatment. Dramatic impact of the artificial nutrition on the management of short bowel syndrome, with 7 cases (residual small bowel from 75 to 9 cm, mean 40 cm) successfully treated. Surgical technique. Confirmed the validity of the one-stage termino-terminal anastomosis. Prognosis. Significant improvement in the last three decades respectively with 50%, 87% and 93% of long-term survivors. In the first decade 6 over 8 deaths were related to the atresia, while in the last 10 years the only death recorded was related to an associated severe cardiac malformation.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Intestinal Obstruction I: Introduction
Anatomy of the Intestines
Intestinal Obstruction II: Pathophysiology

